Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unsuspected somatic mosaicism for FBN1 gene contributes to Marfan syndrome.
Arnaud P, Morel H, Milleron O, Gouya L, Francannet C, Da Costa A, Le Goff C, Jondeau G, Boileau C, Hanna N. Arnaud P, et al. Among authors: morel h. Genet Med. 2021 May;23(5):865-871. doi: 10.1038/s41436-020-01078-6. Epub 2021 Jan 25. Genet Med. 2021. PMID: 33495528 Free PMC article.
Various Genital and Reproductive Phenotypes in 46,XX/46,XY Chimeras.
Hercent A, Amar E, Valent A, Belloc S, Ferraretto X, Hermieu JF, Battin-Bertho R, Storey C, Goubin-Versini I, Dijoud F, Tabet AC, Chantot-Bastaraud S, Peycelon M, Morel H, Siffroi JP. Hercent A, et al. Among authors: morel h. Sex Dev. 2019;13(5-6):271-277. doi: 10.1159/000510532. Epub 2020 Sep 19. Sex Dev. 2019. PMID: 32961533
End-Truncated LAMB1 Causes a Hippocampal Memory Defect and a Leukoencephalopathy.
Aloui C, Hervé D, Marenne G, Savenier F, Le Guennec K, Bergametti F, Verdura E, Ludwig TE, Lebenberg J, Jabeur W, Morel H, Coste T, Demarquay G, Bachoumas P, Cogez J, Mathey G, Bernard E; FREX consortium; Chabriat H, Génin E, Tournier-Lasserve E. Aloui C, et al. Among authors: morel h. Ann Neurol. 2021 Dec;90(6):962-975. doi: 10.1002/ana.26242. Epub 2021 Oct 20. Ann Neurol. 2021. PMID: 34606115
Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study).
Amari L, Tomasini P, Dantony E, Rousseau-Bussac G, Ricordel C, Bigay-Game L, Arpin D, Morel H, Veillon R, Justeau G, Huchot E, Fournel P, Vergnenegre A, Bizeux A, Subtil F, Clarisse B, Decroisette C, Chouaid C, Greillier L, Bylicki O. Amari L, et al. Among authors: morel h. Lung Cancer. 2024 May 31;193:107843. doi: 10.1016/j.lungcan.2024.107843. Online ahead of print. Lung Cancer. 2024. PMID: 38830303
101 results